jba shekhar in vitro

Upload: avanish-verma

Post on 06-Jul-2018

223 views

Category:

Documents


0 download

TRANSCRIPT

  • 8/18/2019 JBA Shekhar in Vitro

    1/14

     Article

    In vitro  biocompatibility of novelbiphasic calcium phosphate-mullitecomposites

    Shekhar Nath, Sushma Kalmodia and Bikramjit Basu

    Abstract

    In designing new calcium phosphate (CaP)-based composites, the improvement in physical properties (strength, tough-ness) without compromising the biocompatibility aspect is essential. In a recent study, it has been demonstrated thatsignificant improvement in compressive strength as well as modest enhancement in toughness is achievable in biphasiccalcium phosphate (BCP)-based composites with mullite addition (up to 30 wt%). Herein, we report the results of thein vitro cell adhesion, cell proliferation, alkaline phosphatase (ALP) activity, and osteocalcin (OC) production for a seriesof BCP-mullite (up to 30 wt%) composites. Mouse fibroblast (L929) cell lines were used to examine  in vitro cell adhesionand cell proliferation; while osteoblast-like (osteosarcoma, MG63) cells were used for  in vitro osteoblastic function studyby ALP and OC expression. Much emphasis has been provided to discuss the cell viability and proliferation as well asosteoblastic differentiation marker on the investigated biocomposites in relation to the characteristics of the phaseassemblage. On the basis of various observations using multiple biochemical assays, it has been suggested that BCP-mullite composites would be a candidate material for orthopedic applications.

    Keywords

    BCP-mullite, composite, cell adhesion, MTT, ALP, osteocalcin

    Introduction

    In the search of ideal bioactive bone implant materials,

    substantial efforts have been invested to develop

    hydroxyapatite (HA) or CaP-based composites with

    various reinforcements.1–4 As a synthetic analogue of 

    calcified tissues of vertebrate, HA is a candidate mate-

    rial for bone implant applications. Also, bone matrix

    can directly bind to HA, which is a necessary prerequi-

    site for implant osseointegration.5 However, its low

    strength and fracture toughness have reduced the field

    of possible applications only to those, where the

    implant will be subjected to very low stress.6–8

    Another possible application of HA could be a coating

    on metallic implants. However, recent clinical stud-

    ies9,10 revealed that HA coating did not produce any

    benefit, when implanted for long period. Keeping these

    information in mind, it is therefore needed to improve

    the performance of CaP (HA, tricalcium phosphate – 

    TCP]), which could be used as bulk. In search of such

    materials, researchers used mixture of HA-TCP mate-

    rials along with second phase reinforcement to develop

    composites with desirable properties. To this end, the

    physical property enhancement without any compro-

    mise on biocompatibility aspect necessitates the use of 

    optimal amount of reinforcement as well as tailoring

    the processing parameters.

    For this purpose, in the present study, different

    amounts (10–30 wt%) of mullite (3Al2O3.2SiO2) were

    mixed with HA and the powder mixtures were sintered

    under various optimal conditions. Mullite is a solid

    solution of alumina (Al2

    O3

    ) and silica (SiO2

    ). Mullite

    is chemically inert and mainly used as refractory mate-

    rial in high temperature furnaces.11 It has lower density

     Journal of Biomaterials Applications

    27(5) 497–509

    ! The Author(s) 2011

    Reprints and permissions:

    sagepub.co.uk/journalsPermissions.nav

    DOI: 10.1177/0885328211412206

     jba.sagepub.com

    Laboratory for Biomaterials, Department Materials Science and

    Engineering, Indian Institute of Technology Kanpur, Kanpur 208016, UP,

    India

    Corresponding author:

    Bikramjit Basu, Laboratory for Biomaterials, Department of Materials

    Science and Engineering, Indian Institute of Technology Kanpur, Kanpur

    208016, UP, India.

    Email: [email protected]

  • 8/18/2019 JBA Shekhar in Vitro

    2/14

    (3.05 g/cc) than Al2O3 (3.95 g/cc) and ZrO2 (6.1g/

    cc). It has good combination of structural properties,

    like high hardness of 15 GPa, high elastic modulus of 

    240 GPa, and moderate fracture toughness of 

    3 M Pa m0.5.12 When mullite was mixed (up to

    30 wt%) with HA, very good combinations of mechan-

    ical properties were measured (E-modulus: 70 GPa,hardness: 4–5 GPa, and fracture toughness: 1.5 MPa

    m0.5).13 This toughness value was 2.5 times higher

    than that of pure monolithic HA (0.6MPa m0.5,

    measured by SEVNB technique). The compressive

    strength of the developed composites was 230MPa,

    which is by far better than pure HA (50 MPa).13

    From microstructural phase assemblage point of 

    view, these composites contain a mixture of HA and

    TCP and therefore they are called as biphasic calcium

    phosphate (BCP)-mullite composites.14–16 Hence, it is

    likely that such composite could be an excellent alter-

    native of HA, provided that the composite shows

    required biocompatibility.

    In this backdrop, an important part of research is to

    characterize the in vitro   properties of new biomaterials.

    Despite various conflicts in results of  in vitro and  in vivo

    tests, the in vitro assays are considered the primary bio-

    compatibility screening tests for a wide variety of 

    implant materials.17 For example, the response of oste-

    oblastic cells to a thin film of poorly crystalline calcium

    phosphate apatite (PCA) crystals was examined  in vitro.

    The osteoblasts were reported to exhibit high cellular

    activity, such as adhesion, proliferation etc. In fact, the

    cells were attached more rapidly to PCA thin film than

    to reference dishes.18

    In another study, HA was used asan additive for zirconia-alumina nanocomposite. The

    addition of HA was reported to increase the biocom-

    patibility of the nanocomposites significantly, as evi-

    dent from the results of the   in vitro   tests using MG63

    osteoblast-like cells.5 In some cases, the HA-based

    composite materials showed better   in vitro  biocompat-

    ibility than pure HA. For example, Boanini et al.19

    studied the interaction of osteoblast-like cells on nano-

    composite of HA with aspartic acid and glutamic acid.

    Their results revealed that the nanocomposite of 

    HA possessed better cell proliferation, alkaline phos-

    phatase (ALP) activity, and osteocalcin (OC) gene

    expression than pure HA. Shu et al.20 studied the role

    of HA on the differentiation and growth of MC3T3-E1

    osteoblasts cells. Their results indicated that HA

    enhanced osteoblast differentiation while suppressing

    cell growth. In contrast, Licht et al.21 reported that

    due to the phagocytosis of HA particles, osteoblast

    exhibited reduced cell growth and ALP activity.

    In another study, Ogata et al.22 compared the osteo-

    blast response to HA with HA/soluble CaP (SCaP)

    composites. Their results revealed that HA/CaP

    showed greater ability in osteogenesis than HA by

    increasing collagen synthesis and calcification of the

    extracellular matrix.

    Reviewing literature, it is evident that HA, TCP, and

    other CaP phases are biocompatible. However, there is

    no published data available on the biocompatibility of 

    mullite ceramics. Therefore, the biocompatibility of BCP-mullite composite materials is needed to be exam-

    ined before any biomedical application can be pro-

    posed. In this paper, we report the cell adhesion,

    proliferation, and differentiation behavior using

    mouse fibroblast (L929) as well as MG63 cell lines.

    The sintered HA was used as baseline material in all

    the  in vitro  experiments.

    Materials and experimental procedures

    Synthesis of materialsHA powder was synthesized in-house using commer-

    cially available chemicals, such as calcium oxide

    (CaO) and phosphoric acid (H3PO4), following a well-

    established suspension–precipitation route.23,24 Phase

    pure mullite (3Al2O3.2SiO2) powder was procured com-

    mercially (KCM Corporation, Japan). As a first step of 

    sample preparation, the mixing of HA and mullite pow-

    ders (10–30 wt% mullite) was carried out in a ball mill

    for 16 h. Following this, the powder was subsequently

    pressed to obtain pellets of 5 mm diameter. The sinter-

    ing temperature was optimized based on the densifica-

    tion and mechanical properties results. The sintering of the composite pellets was carried out at 1350C for 2 h,

    while sintering of pure HA was performed at 1200C

    for 2 h, both in conventional pressureless sintering fur-

    nace. After the sintering, the diameter of the sample

    was around 4 mm. The sintered composites are desig-

    nated by their initial mullite content (BCP M means

    BCP – x wt% mullite and likewise), irrespective of the

    phases present in the sintered materials. Therefore,

    throughout the text, such designation is followed for

    the composites.

    Material characterizationX-ray diffraction (Rich-Seifert, 2000 D) patterns were

    acquired from the sintered ceramics to identify the dif-

    ferent phases present. Based on the X-ray peak inten-

    sity of the characteristic phases, the qualitative presence

    of various phases is reported in this paper. Scanning

    electron microscopy (SEM; model JSM-6330F,

    Philips, The Netherlands) was performed on the pol-

    ished and etched surface of the sintered composite to

    investigate various microstructural features.

    498   Journal of Biomaterials Applications 27(5)

  • 8/18/2019 JBA Shekhar in Vitro

    3/14

    Surface topography is an important parameter

    which, influences the cell adhesion and, in general, the

    biocompatibility property of materials. In order to

    characterize the finer scale topography of the investi-

    gated materials, smoothly polished and thermally

    etched surfaces were observed under atomic force

    microscope (AFM; Molecular Imaging, Pico-SPM I,USA) using ‘contact mode’. A Si3N4  cantilever with a

    three-sided pyramidal single crystal Si3N4 tip with apex

    angle of 20, a tip radius of curvature of 10 nm, and a

    normal stiffness of  0.6 N/m were employed.

    Cell culture experiment.   L929 and MG63 cell linesobtained from CCMB, Hyderabad (India), and

    ATCC (USA), respectably were preserved in an LN2container. Prior to seeding the cells on biomaterials

    surfaces, the cells were revived. Following this, cells

    were cultured in Dulbecco’s modified Eagle’s medium

    (DMEM; Sigma Aldrich), supplemented with 10% fetal

    bovine serum (Sigma Aldrich) and 1% penicillin/strep-

    tomycin cocktail (Sigma Aldrich). The culture plate

    with the cell lines (gelatin-coated) was incubated for

    further proliferation and growth in a CO2   incubator

    (Thermo, USA) operated under conditions of 5%

    CO2, 90% humidity, and 37C temperature. The

    medium was being replaced every 2 d interval and the

    numbers of cells in confluent monolayer was approxi-

    mately 5 105/mL, in 35-mm culture plate. The conflu-

    ent monolayer was detached from the culture plate

    using 0.50% trypsin and 0.20% EDTA solution

    (Sigma Aldrich).

    Cell adhesion test.   As described in the previous sub-section (section ‘Cell culture experiment’), L929 cells

    were cultured. The samples used for cell adhesion

    experiment were pure HA, BCP10M, BCP20M,

    BCP30M, and control glass disc. All samples were ster-

    ilized in steam autoclave (121C, 15 lb pressure for

    15 min) and, subsequently, the cells were seeded on

    the samples at approximate density of 5 105/mL. In

    a separate experiment, the cell seeding density of L929

    was reduced to 1 105/mL and the effect of cell seeding

    density on cell adhesion was studied. The seeded test

    samples were incubated in a CO2

      incubator with the

    standard culture condition, 5% CO2, 37C tempera-

    ture, and 90% humidity. The culture medium was

    being aspirated after 2-d interval and fresh culture

    medium was being added into each wells. After the

    stipulated time period (1 and 3 d), the samples were

    washed twice with phosphate buffer saline (PBS;

    1PBS, pH 7.4) and then fixed by 2% glutaraldehyde

    in PBS. The cells, adhered on the material surfaces,

    were dehydrated using a series of ethanol solutions

    (30%, 50%, 70%, 95%, 100%) for 10 min twice and

    then further dried using critical point drier (CPD;

    Quramtech, UK). The dried samples were sputter-

    coated (Vacuum Tech, Bangalore, India) with gold

    and examined under SEM. For AFM observation, the

    dried samples were directly used, without gold coating.

    The experiment was repeated for at least three times

    and the representative results are presented in the pre-sent article.

    MTT assay 

    L929 and MG63 cells were cultured following the pre-

    viously described cell culture method. The cell prolifer-

    ation was investigated on pure HA, BCP-mullite

    composites (4 mm diameter, 4 mm height), and control

    glass disc. At first, autoclaved samples were placed in

    the 4-well plate and then washed with PBS. Following

    this, 5 104 cells/mL were seeded on each sample.

    Subsequently, the culture plate was incubated for 2 d

    in the CO2  incubator. After the incubation period, the

    medium was aspirated and samples were washed

    twice with PBS. Then, 200mL of fresh DMEM was

    added (without phenol red) into each well followed

    by 10 mL reconstitute MTT (3(4,5-dimethylthiazol-2

    yl)-2-5 diphenyltetrazolium bromide: SIGMA, USA,

    Cat No.M5655; 5 mg/mL in DMEM culture medium

    and serum) per 100 mL of DMEM was added in

    each well and the plate was incubated for 6–8 h. In

    the meantime, the culture plate was viewed under the

    phase contrast microscope (Nikon, Eclipse 80i, Japan)

    to check for the formation of purple formazane

    crystal. After the incubation, samples were removedfrom the wells and placed in a new culture plate.

    Thereafter, 200mL of dimethyl sulfoxide (DMSO)

    was added into each well, including control. The opti-

    cal density of the solution was measured at 540 nm

    using ELISA automated microplate reader (Bio-Tek,

    EL 800).

     ALP activities

    ALP is a widely recognized biochemical marker to

    assess osteoblast activity on biomaterial substrate. It

    is known that ALP plays a major role in skeletal min-

    eralization. This enzyme is bound to the membrane of 

    osteoblasts and functions to enhance osteogenesis by

    degrading pyrophosphates. For the ALP assay, the

    autoclaved samples were placed in the 4-well plates

    and MG63 cells were seeded approximately at a density

    of 5 104 cells/mL. Three replicates of each composi-

    tion were selected for this experiment. The culture pro-

    tocol and conditions were similar to that described in

    the earlier section. After 2 d of culture, ascorbic

    acid and vitamin D3 were added to activate the

    Nath et al.   499

  • 8/18/2019 JBA Shekhar in Vitro

    4/14

    phenotypic expression of differentiated MG63 cell line.

    The concentration of 1,25-dihydroxy vitamin D3 solu-

    tion has significant effect on the expression of differen-

    tiated MG63 cells. In an important study, Robert and

    Gideon25 reported that the concentration of 108 –107

    M, 1,25-dihydroxy vitamin D3 inhibited growth and

    elevated ALP as well as total cell protein. However,lower D3 concentrations (1010 and 109 M) reduced

    ALP activity. Therefore, in the present study, the con-

    centration of vitamin D3 was kept at 108 –107 M for

    better ALP activity.

    The ALP activity experiments were conducted after

    3 rd and 7th d of culture. When the cells were lysed

    followed by centrifuged. Therefore, the supernatant

    was used as the ‘sample’ for the ALP activity. The sub-

    sequent steps were followed as per the commercial kit

    protocol (ALP, code no. 25904, Span Diagonstics Ltd.,

    Surat, India) in a 96-well culture plate. At the last step

    of the experiment, optical density was measured by

    ELISA reader at 405nm.

    Osteocalcin.   It is known that OC, the most abundantnoncollageneous protein of the bone extracellular

    matrix, is biologically synthesized by osteoblast-like

    cells. In the present study, MG63 cells were cultured

    for the OC assay, following the method described in

    an earlier section. After subconfluent, cells were trypsi-

    nized and seeded on sterilized pure HA and BCP-mul-

    lite (all samples were of 4 mm diameter) in a 4 well

    culture plate at a density of 5 104 cells/mL. After

    day 2 and 5, culture medium was replaced by differen-tiating medium that contain vitamin D3 (108 M final

    concentration), ascorbic acid (50mg/mL final), and

    glycerol phosphate (108 mg/mL) to enhance osteogenic

    activity. OC production was tested at 7th d of cul-

    ture and the sample preparation was similar to ALP

    assay. In brief, three strips of coated wells were taken

    from the strips supplied with the OC kit (HOST-

    EASIA KAP1381, Biosource Europe S.A., Belgium).

    Thereafter, 25mL of each calibrator (human serum

    with protease inhibitors and benzamidin: supplied

    with kit), control (human serum with protease inhibi-

    tors, benzamidin and thymol: supplied with OC kit)

    and samples (Pure HA, BCP10M, BCP20M, and

    BCP30M) were transferred into the appropriate wells

    and subsequently 100mL of anti-OST-HRP conjugate

    was added to all the wells, followed by 2 h shaking.

    Following this, the liquid from each well was aspirated

    and washed by 400 mL of wash solution. Then, the solu-

    tion from each well was aspirated and 100 mL of chro-

    mogenic solution was added into each well. Thereafter,

    the well plate was incubated in a shaker at room tem-

    perature. Finally, the optical density was measured at

    450 nm.

    Results

    Phase assemblages and microstructure.   In Table 1,the quantitative analysis of XRD results, obtained from

    the polished surface of the investigated materials, are

    presented. Also, a typical microstructure of BCP30M

    composite is provided in Figure 1. The larger grainmatrix was identified as TCP/HA phase and the grain

    boundary phases were mullite, alumina, CaO, and geh-

    lenite. More details of the microstructural characteriza-

    tion can be found elsewhere.15,16 From Table 1 it

    should be clear that all the HA-based composites

    after sintering predominantly contained TCP. In con-

    trast, single-phase HA without any sign of dissociation

    to any TCP polymorph could be obtained as baseline

    HA. The addition of mullite as well as higher sintering

    temperature, in combination, caused dissociation of 

    HA to TCP phases and it is clear that all the mullite-

    containing samples were essentially BCP composites.

    In Fig. 2, AFM images show some representative

    surface topography (three-dimensional view). Figure

    2(a) shows the equiaxed grains of HA of variable

    sizes with good grain boundary adhesion. Figure 2(b)

    shows the AFM image captured from BCP10M sample,

    sintered at 1350C for 2h. Here, the finer grains of 

    reaction products were present at the boundary region

    of larger HA/TCP grains. Similarly, Figure 2(c) shows

    a coarse CaP-grain surrounded by the reaction prod-

    ucts, that is, calcium–alumino silicate phase. Figure

    2(d) presents a high magnification AFM image of 

    BCP30M sample and the grain boundary area was

    almost covered by the reaction products. In all theinvestigated samples, the grain boundary phases

    appeared to be well bonded with the matrix phase,

    that is, HA/TCP. Also, the crystals of grain boundary

    phases were much smaller (less than 300 nm) compared

    to that of the matrix phase.

    Cell adhesion.   Figure 3 shows the cell adhesion behav-ior of BCP20M (Figure 3(a) and (b)), BCP30M

    (Figure 3(c) and (d)), and control (Figure 3(e) and

    (f)) samples, after 1 d of culture. Here, the cell seeding

    density was 5 105 cells/mL. In all cases, cell division,

    proliferation and cell–cell contacts were evident.

    Clearly, as far as the cell adhesion was concerned, var-

    ious composites, despite compositional difference/phase

    assemblage, exhibited comparable behavior. Also, the

    cell adhesion for investigated ceramics was comparable

    with that of control sample. Beside major observation

    of cell spreading, a transient signal of cell migration

    was also observed through structural changes in the

    form of cell protrusion.

    More detailed observations of cell–material interac-

    tion are made with SEM and AFM. Figure 4 shows the

    results of similar cell adhesion experiments, but the

    500   Journal of Biomaterials Applications 27(5)

  • 8/18/2019 JBA Shekhar in Vitro

    5/14

    culture time was more (3 d) and the cell seeding density

    was approximately 1 105/mL. SEM images reveal

    adhesion of L929 cells on BCP10M (Figure 4(c) and

    (d)), BCP20M (Figure 4(e) and (f)), BCP30M

    (Figure 4(g) and (h)) samples. The cell adhesion on

    baseline HA sample can be seen in Figure 4(a) and

    (b). From the images, some interesting observations

    can be made, for example, Figure 4(e) reveals how the

    cells were connected to each other by filapodia exten-

    sion on BCP20M sample. In this case, some observable

    differences could be found, when the cell seeding den-

    sity was lower. The cells were larger in size with an

    approximate dimension of 40–50mm. The major differ-

    ence could be found in cell morphology. In case of cell

    density being 1 105/mL, most of the cells were spread

    on the surface and intended to enhance the cell-material

    contacts. The filopodia of the cells were extended over

    longer distance than that was observed in the previous

    case (when cell seeding density was 5 105/mL) on the

    materials surface. Figure 4(i) shows an AFM image of a

    filapodia attached on pure HA sample. The branching

    of filapodia is clearly visible. This type of branching

    provided good anchorage with the material surface.

    MTT assay.   It is known that MTT reagent directlyreacts with the mitochondria (mitochondrial dehydro-

    genase) of living cells. Therefore, the reduction of MTT

    will be more if more numbers of metabolically active

    cells are present. In this context, MTT is widely

    regarded as one of the quantitative assays to determine

    the cytotoxicity of the materials, detecting the cell via-

    bility on the sample surface. The measured optical den-

    sity, as recorded with ELISA plate reader, is directlyproportional to the number of viable cells in the culture

    medium.

    Figures 5(a) and (b) plot the MTT assay results

    obtained using MG63 and L929 cells, respectively. In

    both the plots, the results are compared in reference to

    pure HA. Figure 5(a) shows that in all the mullite-con-

    taining composites, the numbers of metabolically active

    cells were comparable to pure HA. BCP10M, BCP20M,

    and BCP30M possessed 103%, 113%, and 101% cell

    viability, respectively, compared to pure HA. Similar to

    these results, Figure 5(b) shows the result of MTT assay

    using L929 cells. Here also, the result obtained with HA

    was considered as baseline observation (control).

    Again, the MTT reduction rate data revealed that

    both BCP10M and BCP20M, in average, possessed

    similar or slightly better cell viability than pure HA.

    Owing to the fact that error bars overlap among vari-

    ous MTT datasets, no statistical significance could be

    confirmed in terms of cell viability.

     ALP activities.   ALP activity is considered as a pheno-typic marker of differentiated cell. The ALP produced

    by metabolically active MG63 cells, after 3 and 7 d of 

    Table 1.  The starting powder composition and sintering conditions are mentioned as well as the sample designation of each sample

    used in the present investigation.

    Sample designation Starting composition

    Pressureless sintering

    conditions Phase assemblages (after sintering)

    HA Pure HA 1200C, 2 h HA-ss

    BCP10M HA with 10 wt% mullite 1350

    C, 2 h   a-TCP-ss, HA-ss, b-TCP-w, mullite-ww,CaO-ww

    BCP20M HA with 20 wt% mullite 1350C, 2 h   a-TCP-s, b-TCP-ss, HA-ww, mullite-w,

    gehlenite-ww, CaO-ww, alumina-ww

    BCP30M HA with 30 wt% mullite 1350C, 2 h   b-TCP-ss, HA-ww, mullite-s, gehlenite-

    ww, CaO-ww, alumina-ww

    The phases present in the sintered ceramics are summarized based on the XRD peak intensities.

    Ss: very strong, s: strong, ww: very weak, w: weak.

    Figure 1.  Representative microstructure of thermally etched

    BCP30M ceramic. Note the uniform presence of grain boundary

    phases around each grain.

    Nath et al.   501

  • 8/18/2019 JBA Shekhar in Vitro

    6/14

    experiments, is quantitatively plotted in Figure 6. After

    3 d of culture, the maximum ALP activity was mea-

    sured with pure HA and for composites (10–30 wt%

    mullite) the ALP activity was very near to pure HAp.

    After 7 d of culture, the ALP expression of the cultured

    cells was significantly higher in all mullite-containing

    composite with respect to pure HA. However, almost

    no difference in terms of ALP expression was found

    among various mullite-containing composites.

    Osteocalcin.   OC is a later stage marker of bone celldifferentiation. Declercq et al.26 described calcification

    as a predictor of bone mineralization capacity of bio-

    materials in osteoblastic cell cultures. It is normally

    accepted that the OC production measurement is

    important to substantiate the use of investigated cera-

    mics as bone replacement materials. As part of the pre-

    sent study, the results of the OC assay, are plotted in

    Figure 7. The OC production after 7 d of culture on

    control, pure HA, and BCP10M showed significantly

    lower values in comparison with BCP20M and

    BCP30M samples. However, no difference in OC pro-

    duction could be noticed between BCP20M and

    BCP30M samples.

    Figure 2.  AFM images showing the surface topography of the various investigated materials: (a) pure HA sintered at 1200C for 2h

    and the composites: (b) BCP10M, (c) BCP20M, and (d) BCP30M samples, all sintered at 1350C for 2 h. GB represents ‘grain

    boundary.’

    502   Journal of Biomaterials Applications 27(5)

  • 8/18/2019 JBA Shekhar in Vitro

    7/14

    Figure 3.  Selected SEM images illustrating the adhesion of L 929 cells on various material surfaces – BCP20M (a, b), BCP30 M (c, d),

    and negative control sample (e, f) after  in vitro  culture for 1 d.

    Nath et al.   503

  • 8/18/2019 JBA Shekhar in Vitro

    8/14

    Discussion

    This study demonstrates that the biological response of 

    BCP (HA and TCP) ceramics containing 20 and

    30 wt% mullite is comparable (as per cell adhesion,

    MTT) or better (ALP and OC results) than pure HA.

    It is indeed an important result that the presence of 

    mullite did not affect the cellular viability property on

    BCP-mullite composites, when compared to sintered

    HA monolith. In the following, results will be inter-

    preted in terms of the substrate compositional differ-

    ences or phase assemblage. Such interpretation will be

    helpful to realize the following aspects: (a) In vitro cyto-

    compatibility property on the basis of microstructural

    phase assemblages; (b) prediction of osteoconduction

    property based on biocompatibility with MG 63 cell

    line; and (c) bone-cell functionality and phenotypic

    marker expression based on ALP and OC expression

    assay.

    Materials and microstructure effect oncytocompatibility.  In recent years, the mixture of HAand TCP ceramics has been reported to be better than

    the monolithic forms of the either (HA or TCP) due to

    the controlled resorbability of BCP ceramics. In an

    interesting work, Arinzeh et al.27 studied the bone for-

    mation capabilities of BCP ceramics using human

    Figure 4.  SEM images of L929 cells adhered on pure HA (a, b), BCP10M (c, d), BCP20M (e, f), and BCP30M samples (g, h). AFM

    image revealing extensive filopodia extension on pure HA sample is also shown (i). Results were obtained after 3 d of culture. The

    seeded cell density was 1105 cells/mL.

    504   Journal of Biomaterials Applications 27(5)

  • 8/18/2019 JBA Shekhar in Vitro

    9/14

    mesenchymal stem cells. The results revealed that HA :

    TCP ratio of 20:80 was the optimum combination for

    better bone formation, whereas pure HA and TCP

    phase had much less effect on bone formation. A

    closer look at Table 1 further reveals that while   a-

    TCP dominated in BCP10M material,  b-TCP was the

    major phase in BCP20M and BCP30M composites.

    The additional presence of CaO, Al2O3, and gehlenite,

    all in minor amounts (much weaker X-ray peak inten-

    sity), was also noticed. From the examples mentioned

    in introduction part, it is quite clear that pure HA and

    TCP are undoubtedly biocompatible material.

    However, the presence of other calcium-alumino-sili-

    cate phases may also have an influence on the biocom-

    patibility of this material. In some earlier reported

    results,28,29 it was mentioned that the biocompatibility

    of the materials mainly depended on the leaching of 

    ions. The adhered cells mainly proliferate and differen-

    tiate due to the activation of surface ions. In the present

    case, the possible leaching ions would be Ca, P, Si, and

    Al. The effect of Ca and P ions need not be discussed

    here, as these are already known marker for the bio-

    mineralization.30 The effects of other ions, therefore,

    need to be discussed with cited literature. For example,

    silicon-containing materials were already investigated

    as silicon-substituted HA, Si3N4, etc. Thain et al.31

    (a)130

    120

    110

    100

    90

    80

    70

    60

    50BCP10M

       M  e   t  a   b  o   l   i  c  a   l   l  y  a  c   t   i  v  e  c

      e   l   l  s   (   %    P

      u  r  e   H   A   )

    BCP20M BCP30M

    (b)130

    120

    110

    100

    90

    80

    70

    60

    50BCP10M

       M  e   t  a   b  o   l   i  c  a   l   l  y  a  c   t   i  v  e  c  e   l   l  s   (   %    P

      u  r  e   H   A   )

    BCP20MSamples

    BCP30M

    Figure 5.   MTT assay results showing the relative number of 

    metabolically active (a) MG63 cells (b) L929 adhered on pure HA,

    BCP10M, BCP20M, and BCP30M samples. In (a) and (b), theresults were compared with pure HA. The results are shown

    after 2 d of culture.

    3.00

    2.50

    2.00

    1.50

    1.00

    0.50

    0.00

    Pure HA BCP10M BCP20MSamples

    Days of culture

       M  e  a  n  o  p   t   i  c  a   l   d  e  n  s   i   t  y   (   4

       0   5  n  m   )

    3.007.00

    BCP30M

    Figure 6.  ALP activity of MG63 cells on pure HA, BCP10M,

    BCP20M, and BCP30M ceramics, after 3 and 7 d of culture in

    osteogenic medium.

    60

    50

    40

    30

    20

    10

    0Control Pure HA BCP10M

    Samples

       O  s   t  e  o  c  a   l  c   i  n   (  n  g   /  m   L   )

    BCP20M BCP30M

    Figure 7.  OC expression of cultured MG63 cells on various

    ceramics samples after 7 d of culture. The results were compared

    with control solution supplied with the kit.

    Nath et al.   505

  • 8/18/2019 JBA Shekhar in Vitro

    10/14

    described the in vitro   biocompatibility of silicon-substi-

    tuted HA thin film and reported that the presence of Si

    did not induce any toxic effect. In another study, Kue

    et al.32 showed enhanced cell proliferation and OC pro-

    duction by human osteoblast-like MG63 cells on silicon

    nitride ceramic discs. Their results revealed that Si3N4

    was a nontoxic biocompatible ceramic, which could beused as a potential biomaterial. This proves that the

    presence of Si in the composite, should not ide-

    ally degrade the biocompatibility. As far as the Al-

    leaching is concerned, a study by Ku et al. on Ti-6Al-

    4 V alloy suggested that the release kinetics of Al-ions

    could play a major role in influencing the osteoblast

    behavior.28

    Figure 1 shows some residual porosity mainly at

    intragranular and few at intergranular regions. In gen-

    eral, porosity degrades mechanical properties, but

    microporosity has specific advantages during the initial

    period of implantation. It should be mentioned here

    that Hornez et al.33 reported that both mesoporosity

    (10–50mm) and microporosity (1–10 mm) in HA essen-

    tially stimulated significant cell growth of MC3T3-E1

    osteoblast cells. The cell viability and cell functions

    were better for microporous samples. The presence of 

    micropores would therefore allow better anchorage

    with bone-forming cells and thus improved the mechan-

    ical attachment of these materials during initial period

    of implantation.34

    Another parameter that is important in the context

    of cell adhesion was the surface roughness. In the pre-

    sent case, any minor difference in cell viability could be

    attributed to difference in surface roughness. The sub-grains are clearly visible in the AFM images, while

    those are not distinct in SEM image (Figure 1). From

    Figure 2, it should also be clear that the presence of 

    large fraction of grain boundary phase increased the

    local surface roughness at the nanoscale and this

    should enhance the cell adhesion property in mullite-

    containing BCP composites.

    In addition, efforts were made to study the adhesion

    and expansion behavior of single cell in isolation and in

    contact with other cells on individual material surface.

    This is important to know how a single cell expands or

    attaches to material surface. The initial attachment of 

    cells is mediated by integrins, which induces dramatic

    cytoskeletal changes leading to cell spreading, develop-

    ment of focal adhesion complexes, cell migration, etc.

    In fact, these are morphological signs, which are usually

    described as overall cell morphology changes when a

    cell recognizes the adsorbed adhesive proteins (and

    their conformation) on a given material surface. The

    cell adhesion and expansion of single cell on various

    material surfaces can be seen in Figure 4(b, d, f, h).

    Among various mammalian cell types, the fibroblast

    is one of the least-differentiated cell lines. When

    fibroblast cells were seeded at lower density, it

    showed higher motility on the material surface. One

    single cell can migrate and construct cell–cell interac-

    tion with a recognizable polarity of movement.35 AFM

    images, presented in Figure 4(i), reveal the evidences of 

    cell migration via the extension of cell filopodium. On

    the other hand, lamellipodia extends the movementtoward the direction of cell travel and at the same

    time adhere on the materials surface.35 When the cell

    density was low, the cell–cell interaction was also lower

    and, hence, the cells interact more with material surface

    by spreading themselves on the surface (Figure 4(e)).

    The unidirectional long filopodia extension from the

    adhered cells often formed well-developed ‘Y’ or star

     junction, as can be seen in Figure 4(e). In such a situ-

    ation, cells were suitable to attach to the substrate and

    grow in size as a part of the cell cycle in presence of 

    some growth factors.35 In contrast, high cell density

    inhibits the growth of normal cells. In a cell crowding

    surface, cell growth is inhibited by cell-to-cell contact

    and as a result, it reduces spreading. The above discus-

    sion corroborates well with the difference in cell size

    and cell spreading, when cell seeding density was

    varied (Figures 3 and 4).

    The attachment of substrate-dependent cells, such as

    fibroblasts and osteoblast, to a substratum (e.g. bioma-

    terial) is a synchronized process involving cytoskeleton

    reorganization, cell spreading, and formation of focal

    contact.36,37 The cell adhesion behavior of pure HA

    and composite samples showed presence of cytoplasmic

    extension, filopodia (Figure 4(a-h)). From Figure 4(a)– 

    (h), it can be said qualitatively that the filopodia wasmore visible in case of pure HA (Figure 4(a) and (b)),

    BCP20M (Figure 4(e) and (f)), and BCP30M

    (Figure 4(g) and (h)) samples. However, the filopodia

    was less visible and the cells surface had minimum

    adhesion on BCP10M sample (Figure 4(c) and (d)).

    BCP20M and BCP30M samples mainly contained

    b-TCP (Table 1), whereas BCP10M mainly contained

    a-TCP. Therefore, the difference in cytocompatibility

    behavior could be attributed to the difference in phase

    assemblage.

    Osteoconduction and biochemical markersof bone turnover.   As mentioned earlier, the aspectsof bone cell differentiation and functionality could be

    explained on the basis of ALP and OC assay results.

    The synthesis of these biochemical markers of bone cell

    increases with the increasing expression of osteoblasts

    and decreases with the maturation of osteoblasts.38 It is

    well known that OC and ALP are the phenotypic mar-

    kers of the late and early stages of differentiation of 

    osteoblast-like cells, respectively. An increased specific

    activity of ALP in a bone cell essentially reflects a shift

    toward a more differentiated state.

    506   Journal of Biomaterials Applications 27(5)

  • 8/18/2019 JBA Shekhar in Vitro

    11/14

    Recalling ALP results after 7 d, it is clear that all the

    mullite-containing composites had comparable expres-

    sion of early stage osteoblast differentiation marker,

    which was much higher than baseline HA. This

    means that osteoblast-like cells were in a better func-

    tionally differentiated state in contact with the BCP-

    mullite composites. Furthermore, the extent of OCexpression in case of BCP20M and BCP30M was

    much higher than both baseline HA and BCP10M.

    The above observations therefore confirmed that

    BCP20M composite could exhibit the best combination

    of OC and ALP expression.

    Our results need to be explained in the perspective of 

    earlier literature reports. In several earlier research

    reports, it was mentioned that among CaP-based mate-

    rials, b-TCP containing composites showed better differ-

    entiation and   in vivo   bone formation/mineralization

    capability. For example, Shiratori et al.39 studied the

    bone-forming ability of   b-TCP, when implanted in

    bone defects of rat femur. Their results revealed that

    b-TCP was an appropriate material for the treatment

    of bone defects. In another study, Matsuno et al.40 com-

    pared the in vitro (ALP) as well as  in vivo behavior of  b-

    TCP/collagen sponge composite with only collagen

    sponge (CS). In the in vitro experiments, human mesen-

    chymal stem cell lines were used and for in vivo  experi-

    ment, the samples were placed under the back skin of 

    nude mice for a time period of up to 12 weeks. Their

    results revealed that the composite containing   b-TCP

    showed better osteogenic properties and had ability to

    promote bone formation. In an interesting study,

    Arinzeh et al.27

    tried to optimize the optimum HA/b-TCP ratio for better stem cell–induced bone formation.

    For this purpose, they selected various ratios of HA :  b-

    TCP, that is, 100:1, 76:24, 63:37, 56:44, 20:80, and 1:100.

    In both in vitro (OC) and in vivo experiments (mouse), it

    was revealed that HA:b-TCP ratio of 20:80 was the best

    combination for new bone formation in bone remodel-

    ing process. It can be further noted that this combination

    showed better results compared to monolithic form of 

    HA and  b-TCP. In fact, all other combination of HA

    and b-TCP showed improved results compared to pure

    HA and b-TCP. At the molecular level, HA phase pro-

    vided the required binding sites, whereas TCP, due to its

    higher dissolution properties, increased the concentra-

    tion of Ca and P locally. All these led to the cascading of 

    differential gene expression and positively increased the

    cell differentiation.41,42

    In the present case, Table 1 clearly shows that both

    BCP20M and BCP30M predominantly contained   b-

    TCP phase, while BCP10M contained more   a-TCP

    phase. On the basis of the above information, it

    should therefore be clear that in view of the dominant

    presence of  b-TCP, both BCP20M and BCP30M exhib-

    ited better expression of osteblastic phenotypic marker

    than BCP10M. The present investigation also recon-

    firmed that single-phase HA had inferior expression

    of differentiated bone cell than BCP microstructure

    containing varying ratio of   b-TCP. Additionally, it

    can be stated that the additional presence of gehlenite,

    alumina, or CaO did not have any inhibitory effect as

    far as the osteoconduction property of BCP20M andBCP30M was concerned. In addition to the differences

    in phase assemblage, the difference in surface roughness

    at nanoscale due to uniform presence of grain bound-

    ary phase could also explain the observed difference in

    osteogenic property in the present case.

    In summary, it is clearly understood from MTT data

    and cell adhesion tests that HA and BCP-mullite sub-

    strates supported comparable number of viable cells.

    This, in combination with all the above observations,

    suggests that BCP-mullite biocomposites should be

    used as a substrate for bone-forming cells.

    Conclusions

    a. The principal finding of the present study is that the

    pressureless sintered BCP-mullite composites favor-

    ably supported cell adhesion of L929 cells   in vitro.

    Also, such observations were independent of mull-

    ite content (up to 30 wt%). The morphology and

    motility of adhered cells was dependent on cell seed-

    ing density.

    b. As far as the quantification of the metabolically

    active cells is concerned (cell viability), MTT

    assay results with fibroblast and osteoblast-likecells did not reveal any statistically significant dif-

    ference in BCP-mullite composites in comparison

    with pure HA. This confirmed that mullite and

    additional presence of various phases (alumina,

    CaO, gehlenite) did not have any toxic effect

    in vitro and the presence of mullite did not degrade

    cell viability with respect to pure HA.

    c. The combination of ALP activity and OC expres-

    sion results indicates that BCP-based composite

    substrates with 20% or 30% mullite supported

    superior osteoconduction than baseline monolithic

    HA ceramic. The presence of predominant  b-TCP

    phase was found to be suitable for osteoblastic

    function and phenotypic expression. The presence

    of additional phases, like gehlenite or alumina, was

    not found to have any inhibitory effect   in vitro.

    Based on all the   in vitro   analysis and observations,

    in combination, BCP-biocomposites containing

    20% or 30% mullite can be considered as suitable

    substrate for bone cell adhesion and proliferation.

    d. AFM study in combination with SEM analysis

    revealed the uniform presence of grain boundary

    reaction phases, which increased the surface

    Nath et al.   507

  • 8/18/2019 JBA Shekhar in Vitro

    12/14

    roughness at the nanoscale. The increased surface

    roughness property could explain better cell adhe-

    sion/proliferation property of BCP-mullite compos-

    ites, compared to single-phase HA.

    Acknowledgements

    The authors wish to thank Department of Biotechnology

    (DBT), Government of India, for the financial help. Thanks

    to Dr Lakshmi Nair of CCMB, Hyderabad, India, for pro-

    viding us L929 cells. Thanks are also due to Dr S. Ganesh and

    S. Mittal of BSBE Department, IIT Kanpur, India, for their

    help during initial period of cell culture experiments.

    References

    1. Nath S and Basu B. Designing materials for hard tissue

    replacements.  J Kor Ceram Soc  2008; 45: 1–29.

    2. Nath S, Bodhak S and Basu B. HDPE-Al2O3-HAp com-

    posites for biomedical applications: processing and char-

    acterization.   J Biomed Mater Res B Appl Biomaterials

    2009; 88B: 1–11.

    3. Nath S, Tripathi R and Basu B. Understanding phase

    stability, microstructure development and biocompatibil-

    ity in calcium phosphate-titania composites, synthesized

    from hydroxyapatite and titanium powder mix. Mater Sci 

    Eng C  2009; 29: 97–107.

    4. Nath S, Kalmodia S and Basu B. Sintering, microstruc-

    ture and  in vitro  properties of HA-10 wt % Ag compos-

    ites.  J Mat Sci Mater Med  2010; 21: 1273–1287.

    5. Kong YM, Bae CJ, Lee SH, Kim HW and Kim HE.

    Improvement in biocompatibility of ZrO2 –Al2O3   nano-

    composite by addition of HA.   Biomaterials   2005; 26:

    509–517.6. Adolfson E, Henning PA and Hermannson L. Phase

    analysis and thermal stability of hot isostatically pressed

    zirconia-hydroxyapatite composites.   J Am Ceram Soc

    2000; 83: 2798–2802.

    7. Clifford A and Hill R. Apatite-mullite glass ceramics.

    J Non-crys Sol  1996; 196: 346–351.

    8. Kim HW, Kong YM, Koh YH and Kim HE. Pressureless

    sintering and mechanical and biological properties of 

    flour-hydroxyapatite composites with zirconia.   J Am

    Ceram Soc  2003; 86: 2019–2026.

    9. Camazzola D, Hammond T, Gandhi R and Davey JR. A

    randomized trial of hydroxyapatite-coated femoral stems

    in total hip arthroplasty a 13-year follow-up.   J Arthrop

    2009; 24: 33–37.

    10. Gandhi R, Davey JR and Mahomed NN.

    Hydroxyapatite coated femoral stems in primary total

    hip arthroplasty.  J Arthrop  2009; 24: 38–42.

    11. Schneider H, Okada K and Pask J.   Mullite and mullite

    ceramics. New York: Wiley, 1994.

    12. Kanzaki S, Tabata H, Kumazawa T and Ohta S.

    Sintering and mechanical properties of stoichiometric

    mullite.  J Am Ceram Soc  1984; 68: C6–C7.

    13. Nath S, Dubey A and Basu B. Mechanical properties

    evaluation of novel calcium phosphate-mullite compos-

    ites.  J Biomat Appl , doi: 10.1177/0885328210393292.

    14. Daculsi G, Laboux O, Malard O and Weiss P. Current

    state of the art of biphasic calcium phosphate biocera-

    mics.  J Mater Sci Mater Med  2003; 14: 195–200.

    15. Nath S, Biswas K, Wang K, Bordia RK and Basu B.

    Sintering, phase stability, and properties of calcium phos-

    phate-mullite composites.   J Am Ceram Soc   2010; 93:

    1639–1649.

    16. Nath S, Biswas K and Basu B. Phase stability and micro-structure development in hydroxyapatite-mullite system.

    Scripta Mater  2008; 58: 1054–1057.

    17. Schottler FJ. Tissue culture methods for determining bio-

    compatibility.  ASTM STP  1983; 810: 19–24.

    18. Hong JY, Kim YJ, Lee H W, Lee WK, Ko JS and

    Kim HM. Osteoblastic cell response to thin film

    of poorly crystalline calcium phosphate apatite

    formed at low temperatures.   Biomaterials   2003; 24:

    2977–2984.

    19. Boanini E, Torricelli P, Gazzano M, Giardino R and

    Bigi A. Nanocomposites of hydroxyapatite with aspartic

    acid and glutamic acid and their interaction with osteo-

    blast-like cells.  Biomaterials  2006; 27: 4428–4433.20. Shu R, McMullen R, Baumann MJ and McCabe LR.

    Hydroxyapatite accelerates differentiation and suppresses

    growth of MC3T3-E1 osteoblasts. J Biomed Mater Res A

    2003; 67: 1196–1204.

    21. Licht BA, Gregoire M, Orly I and Menanteau J. Cellular

    activity of osteoblasts in the presence of hydroxyapatite:

    an  in vitro  experiment.   Biomaterials  1991; 12: 752–756.

    22. Ogata K, Imazato S, Ehara A, Ebisu S, Kinomoto Y,

    Nakano T, et al. Comparison of osteoblast responses to

    hydroxyapatite and hydroxyapatite/soluble calcium

    phosphate composites.  J Biomed Mater Res A   2005; 72:

    127–135.

    23. Rathje W. Zur Kentnis de Phosphate: I. Uber hydroxy-

    apatite.   Bodenk Pflernah  1939; 12: 121–128.24. Santos MH, Oliveira M, Souza LPF, Mansurand HS and

    Vasconcelos WL. Synthesis control and characterization

    of hydroxyapatite prepared by wet precipitation process.

    Mater Res  2004; 7: 625–630.

    25. Robert JM and Gideon AR. The Effect of 1,25(OH)zD3

    on alkaline phosphatase in osteoblastic osteosarcoma

    cell.  J Bio Chem  1982; 257: 3362–3365.

    26. Declercq HA, Verbeeck RMH, Ridder LIFJMD,

    Schacht EH and Cornelissen MJ. Calcification as an indi-

    cator of osteoinductive capacity of biomaterials in osteo-

    blastic cell cultures.   Biomaterials  2005; 26: 4964–4974.

    27. Arinzeh TL, Tran T, Mcalary J and Daculsi G. A com-

    parative study of biphasic calcium phosphate ceramics

    for human mesenchymal stem-cell-induced bone forma-

    tion.   Biomaterials  2005; 26: 3631–3638.

    28. Ku CH, Pioletti DP, Browne M and Gregson PJ. Effect

    of different Ti–6Al–4V surface treatments on osteoblasts

    behavior.   Biomaterials  2002; 23: 1447–1454.

    29. Es-Souni M and Brandies HF. Assessing the biocompat-

    ibility of NiTi shape memory alloys used for medical

    applications.  Anal Bioanal Chem  2005; 381: 557–567.

    30. Koshihara M, Masuyama M, Uehara M and Suzuki K.

    Effect of dietary calcium: phosphorus ratio on bone min-

    eralization and intestinal calcium absorption in ovariec-

    tomized rats.  BioFactors  2004; 22: 39–42.

    508   Journal of Biomaterials Applications 27(5)

  • 8/18/2019 JBA Shekhar in Vitro

    13/14

    31. Thian ES, Huang J, Best SM, Barber ZH, Brooks RA,

    Rushton N, et al. The response of osteoblasts to nano-

    crystalline silicon-substituted hydroxyapatite thin films.

    Biomaterials  2006; 27: 2692–2698.

    32. Kue R, Sohrabi A, Nagle D, Frondoza C and

    Hungerford D. Enhanced proliferation and osteocalcin

    production by human osteoblast-like MG63 cells on sili-

    con nitride ceramic discs.   Biomaterials   1999; 20:1195–1201.

    33. Hornez JC, Chai F, Monchau F, Blanchemain N,

    Descampsand M and Hildebrand HF. Biological and

    physico-chemical assessment of hydroxyapatite (HA)

    with different porosity.  Biomol Eng  2007; 24: 505–509.

    34. Annaz B, Hing KA, Kayser M, Buckland T and

    Silvio LD. Porosity variation in hydroxyapatite and oste-

    oblast morphology: a scanning electron microscopy

    study.  J Microscopy  2004; 215: 100–110.

    35. Freshney RI.  Biology of cultured cells, culture of animal 

    cells: a manual of basic technique, 5th ed. New York: John

    Wiley & Sons, Inc, 2005, p.31–42.

    36. Misra A, Lim RPZ, Wu Z and Thanabalu T. N-WASPplays a critical role in fibroblast adhesion and spreading.

    Biochem Biophy Res Comm  2007; 364: 908–912.

    37. West KA, Zhang H and Brown MC. The LD4 motif of 

    paxillin regulates cell spreading and motility through an

    interaction with paxillin kinase linker (PKL).  J Cell Biol 

    2001; 154: 161–176.

    38. Chang X, Hou ZM, Yasuaki S, Tomoo T and Akira Y.

    Quantitative study of alkaline phosphatase and osteocal-

    cin in the process of new bone.   West China J Stomat

    2005; 23: 424–426.

    39. Shiratori K, Matsuzaka K, Koike Y, Murakami S,

    Shimono M and Inoue T. Bone formation in  b-tricalciumphosphate-filled bone defects of the rat femur: morpho-

    metric analysis and expression of bone related protein

    mRNA.  Biomed Res  2005; 26: 51–59.

    40. Matsuno T, Hashimoto Y, Nakahara T, Kuremoto K,

    Nakamura T and Satoh T.   b-TCP/Collagen sponge

    composite enhances the osteogenic differentiation of 

    mesenchymal stem cells.   J Hard Tissue Bio   2005; 14:

    189–191.

    41. Piattelli A, Scarano A and Mangano C. Clinical and his-

    tologic aspects of biphasic calcium phosphate ceramic

    (BCP) used in connection with implant placement.

    Biomaterials  1996; 17: 1767–1770.

    42. Uoshima MH, Ishikawa I, Kinoshita A, Weng HT andOda S. Clinical and histological observation of replace-

    ment of biphasic calcium phosphate by bone tissue in

    monkeys.  Int J Periodont Rest Dent  1995; 15: 204–213.

    Nath et al.   509

  • 8/18/2019 JBA Shekhar in Vitro

    14/14